TrialScientific reports2025

Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes.

James Goodman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.